Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-07

Clinical Trial Update: Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

View source ↗

Summary

This clinical trial update analyzes discontinuation rates, adherence patterns, hospitalizations, and costs associated with oral anticoagulants in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral anticoagulants (various)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Status: COMPLETED